Study to Reinforce Immunity (STRI) Phase 2 Clinical Trial
Clinical trial NCT05046561 · UNKNOWN
Trial details
- NCT number
- NCT05046561
- Sponsor
- Eyecheck, Inc.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-04
- Primary completion
- 2022-12-01
- Enrollment
- 598
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.